The coronavirus outbreak, though the majority of cases have been in China, has affected many aspects of global life, especially businesses and travel. The virus can be easily spread from person to person by close contact and respiratory droplets from an infected person being inhaled. But while coronavirus has occupied the spotlight, there are still other infectious diseases being tested in China. An analysis can be completed for those other infectious disease clinical trials by using the Clinical Trials Database of GlobalData’s Pharma Intelligence Center. In this article, GlobalData presents such an analysis.

When looking at infectious disease clinical trials in China, completed trials outnumber trials of any other status. Completed clinical trials made up 56.9% of all infectious disease trials in China, with “ongoing, recruiting” following with 18.3%, and “planned” with 13.3%. Suspended/withdrawn/terminated (S/W/T), “ongoing, not recruiting,” and “ongoing, recruiting by invitation” were the three least common, with no more than 6.7% each. This can be seen in Figure 1.

Phase I was the most common current infectious disease clinical trial phase in China with 32.9%, followed by Phase IV (26.9%), Phase II (26.4%), and Phase III with 13.7%. (A small number of Phase 0, Phase I / II, Phase II/III, and Phase III / IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively).

Lastly, when looking at these trials by trial site spread, the majority of the infectious disease trials in China are single country; fewer are multinational. Single country trials outnumbered multinational country clinical trials with 87%.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.